Navigation Links
Pathogenica CSO Speaks at IBC Life Sciences Drug Discovery & Diagnostic Development Week
Date:8/2/2011

CAMBRIDGE, Mass., Aug. 2, 2011 /PRNewswire/ -- Pathogenica, Inc. announced that the Company's Chief Scientific Officer, Graeme Doran, Ph.D., is speaking today at the IBC Life Sciences Drug Discovery & Diagnostic Development Week, in San Francisco.

During the conference, the only event on the application of next generation sequencing technology for research, diagnostic development, and patient care, Dr. Doran will speak on "Next Generation Sequencing & Genomic Medicine." He will present the development of Pathogenica's next generation sequencing assays for clinical diagnostics for greater accuracy at reduced cost. He will focus on Pathogenica's Human Papillomavirus sequencing panel, and demonstration of HPV identification from ThinPrep clinical samples.

"This is a significant demonstration of the utility of our assay for clinical specimens in combination with NGS," said Yemi Adesokan, Ph.D., Pathogenica's CEO. "Our work so far demonstrates that NGS can be applied to routine HPV screening specimens to precisely identify viral sub-types relevant to therapeutic decision-making. The Pathogenica DxSeq probe panels achieve comprehensive coverage of >30 high and low risk HPV strains from a single assay."

The Pathogenica test identified the presence of several HPV sub-types amongst the samples tested (HPV 16, 18, 31, 45, 51, 52, 56, 58, 67, 68, 97), and was able to identify multiple strains infecting a single individual. HPV plays a causative role in a number of cancers, and multiple infections may be of clinical significance and correlate with higher-grade lesions. Sequencing's ability to rapidly identify and quantify multiple infections is a significant advantage for clinicians to understand the impact of these viral subtypes.

In his talk, Dr. Doran will also preview forthcoming clinical applications of next generation sequencing for viral and bacterial genotyping.

Dr. Doran received undergraduate and D.Phil degrees from the
'/>"/>

SOURCE Pathogenica, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. FMC Agricultural Products Executive Bob Trogele Speaks to the Iowa Agribusiness Showcase & Conference
2. Beike Biotechnology CSO Speaks on Role of Stem Cells in Treating Diabetic Foot Disease at IPA Diabetic Foot Care Conference, India
3. Dr. Damien Bates of Organogenesis Speaks on Regenerative Medicine for Opening Night of TEDMED Conference
4. Patent Attorney John Rizvi Speaks at FIME International Medical Expo
5. Matthew Lehman of SPRI Clinical Trials Speaks On Designing Trials For Success At The Trout Group Investor Relations Seminar
6. Dr. Susan Weinschenk, Chief of Technical Staff and Services, Speaks on Neuro Web Design at Persuasive Technologies 2009 Conference and Voices That Matter Web Design Conference
7. Professor K. C. Nicolaou Speaks at WuXi AppTec
8. Dr. Gail Naughton Speaks on Histogen's Business Plan and the Rise of Bioaesthetic Medicine during Commercial Translation of Regenerative Medicine
9. BioMed Realty Trust and BIND Biosciences Sign New Lease at Vassar Street Property
10. Neurocrine Biosciences Reports Second Quarter 2011 Results
11. Sangamo BioSciences Reports Second Quarter 2011 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/22/2014)... 21, 2014 The North American crystal ... North America with analysis and forecast of revenue. This ... is expected to reach $623.6 million by 2018, at ... Browse through the TOC of the North American crystal ... in-depth analysis provided. This also provides a glimpse of ...
(Date:10/22/2014)... San Diego, CA (PRWEB) October 22, 2014 ... laboratory balances from Sartorius, A & D Weighing, ... Sartorius CPA Semi-Micro Balance . The Sartorius ... looking for an affordable high-quality, precise, and user-friendly ... in manufacturing of laboratory equipment, their laboratory balances ...
(Date:10/22/2014)... Oct. 22, 2014   Synthetic Biologics, Inc. ... therapies for serious infections and diseases, announced today that ... Notice of Allowance for a composition of matter patent ... difficile program, SYN-004. This is Synthetic Biologics, first ... U.S. and adds to the Company,s extensive C. ...
(Date:10/22/2014)... and HONG KONG , ... rare disease therapeutics enterprise, announced today that rare disease ... company as vice president, research. Dr. McKew brings more ... key leadership positions at the National Institutes of Health, ... acquisition by Wyeth). Dr. McKew will lead aTyr,s efforts to ...
Breaking Biology Technology:The North American crystal oscillator market is expected to reach $623.6 million by 2018 - New Report by MicroMarket Monitor 2The North American crystal oscillator market is expected to reach $623.6 million by 2018 - New Report by MicroMarket Monitor 3The North American crystal oscillator market is expected to reach $623.6 million by 2018 - New Report by MicroMarket Monitor 4Pipette.com Launches the Addition of Sartorius CPA Semi-Micro Balance to Their Product Portfolio with Special Promotional Pricing 2Pipette.com Launches the Addition of Sartorius CPA Semi-Micro Balance to Their Product Portfolio with Special Promotional Pricing 3Synthetic Biologics Announces Allowance of Key U.S. Composition of Matter Patent for C. difficile Program 2Synthetic Biologics Announces Allowance of Key U.S. Composition of Matter Patent for C. difficile Program 3Synthetic Biologics Announces Allowance of Key U.S. Composition of Matter Patent for C. difficile Program 4aTyr Pharma Appoints John C. McKew, Ph.D., as Vice President, Research 2aTyr Pharma Appoints John C. McKew, Ph.D., as Vice President, Research 3
... 2011 Image Sensing Systems, Inc. (NASDAQ: ISNS ... March 31, 2011. (Logo:   http://photos.prnewswire.com/prnh/20050512/CGISSLOGO ) ... compared to $5.4 million for the same period a year ... quarter of 2011 compared to $2.6 million in the same ...
... May 5, 2011 AlloSource, a leading ... for use in surgical procedures around the world, broke ... their campus.  The construction project, designed by Intergroup Architects ... of more than half of the existing facility. ...
... Sigma Life Science, the innovative biological products ... and King,s College London, today announced an exclusive ... the identification and validation of microRNA (miRNA) targets ... information, visit www.wherebiobegins.com/targetid . miRNAs ...
Cached Biology Technology:Image Sensing Systems Announces First Quarter Financial Results 2Image Sensing Systems Announces First Quarter Financial Results 3Image Sensing Systems Announces First Quarter Financial Results 4Image Sensing Systems Announces First Quarter Financial Results 5AlloSource Starts Construction on New Campus 2AlloSource Starts Construction on New Campus 3Sigma® Life Science and King's College London Co-Developing miRNA Target Identification Technology 2Sigma® Life Science and King's College London Co-Developing miRNA Target Identification Technology 3Sigma® Life Science and King's College London Co-Developing miRNA Target Identification Technology 4
(Date:10/22/2014)... DENVER , Oct. 20, 2014  Leading identity ... years time half of the world,s population will have ... in Europe . Asia ... dominate the market accounting for more than 60% of ... Acuity,s report  -- "The Global National ...
(Date:10/19/2014)... electricity access in India over the last 30 ... carbon emissions growth during that time, according to ... Nature Climate Change ., "Energy access is fundamental ... of life, including education, communication, and health," says ... , While increased energy access is widely agreed ...
(Date:10/18/2014)... referred for evaluation of suspected genetic conditions, whole-exome ... percent, including detection of a number of rare ... according to a study appearing in JAMA ... with the American Society of Human Genetics annual ... coding regions of thousands of genes simultaneously using ...
Breaking Biology News(10 mins):Half the World's Population Will Have Chip-Based National Electronic Identity (eID) Cards by 2018 2Improved electricity access has little impact on climate change 2Whole-exome sequencing shows potential as diagnostic tool 2
... a long time that only 2% -- 3% of human ... genomes -- often referred to as junk DNA -- consists ... into DNA, and then reinserted into a new spot in ... these retroelements. Retroviruses can insinuate themselves into the host's DNA ...
... presented at the CIC bioGUNE hold at ... DNA chip concerning diagnosis and prognosis of ... normal, steatosis and NASH predisposed subjects. , ... of the liver of unknown etiology, characterized ...
... pioneering research into diseases such as Creutzfeld-Jakob Disease (CJD) and ... to a £300,000 grant from the Medical Research Council. , ... probable variant CJD (vCJD) in the UK. This is the ... with prions that is also responsible for the epidemic of ...
Cached Biology News:Chimp genome reveals a retroviral invasion 2Chimp genome reveals a retroviral invasion 3Owl genomics presents a HEPATOCHIP for diagnosis of non-alcoholic steatohepatitis 2
ANTI DEOXY CORTICO...
... Automatic High Sensitivity Laboratory Osmometer for both 0.2 and 2.0 mL samples ... analysis and record keeping. Bar code reading capability with optional scanner. RS-232 ... ... ...
Secure-Seal™ hybridization chamber gasket, eight chambers, 9 mm diameter, 0.8 mm deep *set of 20*...
sodium channel, nonvoltage-gated 1 alpha,...
Biology Products: